Skip to main content
Study

Establishing an international baseline for medication safety in oncology: findings from the 2012 ISMP International Medication Safety Self Assessment for Oncology.

Greenall J, Shastay A, Vaida AJ, et al. Establishing an international baseline for medication safety in oncology: Findings from the 2012 ISMP International Medication Safety Self Assessment® for Oncology. J Oncol Pharm Pract. 2015;21(1):26-35. doi:10.1177/1078155214556522.

Save
Print
December 3, 2014
Greenall J, Shastay A, Vaida AJ, et al. J Oncol Pharm Pract. 2015;21(1):26-35.

In 2012, more than 350 organizations from 13 countries participated in the initial Institute for Safe Medication Practices self-assessment for oncology. This study describes results from this baseline survey, which revealed key opportunities for improvements in the safe delivery of chemotherapy. For example, many institutions have still not followed best practices for the administration of vincristine. In addition, less than half of respondents had fully implemented safety processes for oral chemotherapy orders. A prior AHRQ WebM&M commentary describes a patient who inadvertently received the wrong chemotherapy regimen and explores the high risks associated with inpatient chemotherapy.

Save
Print
Cite
Citation

Greenall J, Shastay A, Vaida AJ, et al. Establishing an international baseline for medication safety in oncology: Findings from the 2012 ISMP International Medication Safety Self Assessment® for Oncology. J Oncol Pharm Pract. 2015;21(1):26-35. doi:10.1177/1078155214556522.

Related Resources